Get started
Author

Panagiotis Theodorou Diamantopoulos

Observed names: Diamantopoulos, Panagiotis T, P Diamantopoulos, P. Diamantopoulos, P.T. Diamantopoulos, PANAGIOTIS DIAMANTOPOULOS, PANAGIOTIS T DIAMANTOPOULOS, Panagiotis Diamantopoulos, Panagiotis T Diamantopoulos, Panagiotis T. Diamantopoulos, Panagiotis T. Diamantopoulos, Panayiotis Diamantopoulos
ORCID: 0000-0003-2692-5944
Observed ORCID: 0000-0003-2692-5944
OpenAlex ID: A5037250948
Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations
2012 · Panagiotis T Diamantopoulos, Maria Michael, et al. · Virology Journal · 243
PDF
Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma
2019 · Eva Kassi, Anna Angelousi, et al. · Cancer Medicine · 58
PDF
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
2020 · Dimitrios C Ziogas, Aikaterini Gkoufa, et al. · Journal for ImmunoTherapy of Cancer · 43
PDF
Bullous Pemphigoid–like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature
2018 · Amalia Anastasopoulou, Georgios Papaxoinis, et al. · Journal of Immunotherapy · 42
PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia
2014 · Panagiotis T. Diamantopoulos, Maria Sofotasiou, et al. · BioMed Research International · 41
PDF
Isolated central nervous system relapses in primary mediastinal large B‐cell lymphoma after CHOP‐like chemotherapy with or without Rituximab
2012 · Sotirios G. Papageorgiou, Panayiotis Diamantopoulos, et al. · Hematological Oncology · 40
Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
2020 · Dimitrios C Ziogas, Frosso Kostantinou, et al. · Journal for ImmunoTherapy of Cancer · 39
PDF
PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
2021 · Christina-Nefeli Kontandreopoulou, Panagiotis T. Diamantopoulos, et al. · Blood Advances · 38
PDF
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis
2019 · Bastian Schilling, Alexander Martens, et al. · Cancer Immunology Immunotherapy · 36
Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab Treatment
2017 · Panagiotis T. Diamantopoulos, Katerina Tsatsou, et al. · Journal of Immunotherapy · 34
Late-onset nivolumab-mediated pneumonitis in a patient with melanoma and multiple immune-related adverse events
2017 · Panagiotis T. Diamantopoulos, Maria Gaggadi, et al. · Melanoma Research · 30
Incomplete Vogt–Koyanagi–Harada disease following treatment with encorafenib and binimetinib for metastatic melanoma
2018 · Panagiotis T. Diamantopoulos, Sofia Stoungioti, et al. · Melanoma Research · 29
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder
2022 · Mariam Markouli, Fauzia Ullah, et al. · Cancers · 26
PDF
Melanoma immunotherapy dominates the field
2016 · Panagiotis Diamantopoulos, Helen Gogas · Annals of Translational Medicine · 24
PDF
Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies
2023 · Amalia Anastasopoulou, Michael Samarkos, et al. · Open Forum Infectious Diseases · 22
PDF
The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
2022 · Christina-Nefeli Kontandreopoulou, Konstantinos Kalopisis, et al. · Frontiers in Oncology · 21
PDF
Diagnosis and treatment complications of primary cardiac lymphoma in an immunocompetent 28-year old man: a case report
2019 · Maria Bonou, Chris J. Kapelios, et al. · BMC Cancer · 19
PDF
Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system
2018 · Panagiotis T. Diamantopoulos, Ioannis Kotsianidis, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 19
The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature
2021 · Amalia Anastasopoulou, Panagiotis T. Diamantopoulos, et al. · Therapeutic Advances in Medical Oncology · 18
Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies
2022 · Panagiotis T. Diamantopoulos, Konstantinos Kalopisis, et al. · European Journal Of Haematology · 17
PDF
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
2020 · Sotirios G. Papageorgiou, Ioannis Kotsianidis, et al. · Therapeutic Advances in Hematology · 17
PDF
Correlation of Fc-γ RIIA polymorphisms with latent Epstein–Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas
2012 · Panagiotis T. Diamantopoulos, Vassiliki Kalotychou, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 17
The outcome of patients with high‐risk MDS achieving stable disease after treatment with 5‐azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group
2018 · Sotirios G. Papageorgiou, Christos K. Kontos, et al. · Hematological Oncology · 14
Concomitant development of neurologic and cardiac immune-related adverse effects in patients treated with immune checkpoint inhibitors for melanoma
2020 · Panagiotis T. Diamantopoulos, Katerina Tsatsou, et al. · Melanoma Research · 13
Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes
2017 · P Diamantopoulos, K Zervakis, et al. · Blood Cancer Journal · 13
PDF
Works count: 187
Citation count: 1,341
H-index: 18
I10-index: 34
Year
Topic
Type